Local Anesthesia Spread After an Erector Spinae Plane Block.
A Magnetic Resonance Study to Evaluate the Spread of Local Anesthesia in Healthy Volunteers Receiving an Ultrasound-guided Erector Spinae Plane Block.
1 other identifier
interventional
10
1 country
1
Brief Summary
This a single-center prospective spread-evaluation study where the primary objective is to assess the spread of local anesthesia in an ESPB using magnetic resonance imaging (MRI). The investigators will include 10 healthy volunteers from the hospitals internal website. All volunteers will receive a one-sided Erector Spinae Plane (ESP) block. 30 min after the block sensitivity to cold and pinprick will be assessed before an MRI is performed after 60 min postblock. An radiology specialist will evaluate the MR images pertaining to the spread of the local anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2021
CompletedFirst Posted
Study publicly available on registry
August 19, 2021
CompletedStudy Start
First participant enrolled
September 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 24, 2022
CompletedSeptember 21, 2022
September 1, 2022
4 months
August 12, 2021
September 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Local anesthesia spread
A 3T MRI examination (Magnetom Skyra, Siemens) will be performed 60 minutes after the injection, covering spine levels Th3 to Th12. 3D T1-weighted sequences with fat suppression as well as a T2-weighted sequence will be performed. The distribution pattern of the ropivacaine-gadolinium solution will be evaluated in the following structures: superficial, paravertebral and intercostal musculature, neural foramina and epidural space.
60-120 min
Study Arms (1)
Erector Spinae Plane Block
OTHERAll volunteers will be given the choice of procedural pain relief in the form of rapifen 0,5-1 mg. All volunteers included will receive an unilateral ESPB at the T7 level with 30 ml of 2,5 mg/ml ropivacaine and a total of 0,3 mmol gadolinium. The intervention will be performed by the PhD candidate connected to the study. The ESPB will be performed under ultrasound guidance, where the needle target is the transverse process of the Th7 vertebra, under the musculus (m.) erector spinae. All volunteers will be tested for cold and pinprick sensation 30 minutes after block completion, and the results plotted on a dermatome map before they undergo an MRI.
Interventions
All volunteers receive an Erector Spinae Plane Block and an MRI.
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- No comorbidity
You may not qualify if:
- Allergy to latex, gadolinium and local anesthesia
- BMI \>40
- Severe renal and/or hepatic disease
- Local infection at the site of injection
- Systemic infection
- AV block 2-3
- Inability to understand written or spoken Norwegian
- Inability to cooperate
- Claustrophobia
- Metal implants not MRI-compatible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ostfold Hospital Trust, Kalnes
Sarpsborg, Østfold fylke, 1714, Norway
Related Publications (1)
Sorenstua M, Zantalis N, Raeder J, Vamnes JS, Leonardsen AL. Spread of local anesthetics after erector spinae plane block: an MRI study in healthy volunteers. Reg Anesth Pain Med. 2023 Feb;48(2):74-79. doi: 10.1136/rapm-2022-104012. Epub 2022 Nov 9.
PMID: 36351741DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie Soerenstua, MD
Sykehuset Ostfold HF
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 12, 2021
First Posted
August 19, 2021
Study Start
September 17, 2021
Primary Completion
January 24, 2022
Study Completion
January 24, 2022
Last Updated
September 21, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- At publication date and for three months.
IPD will be available upon request.